ProCE Banner Activity

Monoclonal Antibodies Are Expanding SARS-CoV-2 Prevention and Treatment Strategies

Conference Coverage
Clinical Thought
Data demonstrate potential for monoclonal antibodies in treatment and prevention of COVID-19 in select patients. Emergence of variants may affect current and future utility and will necessitate discernment from healthcare professionals.

Released: March 09, 2021

Expiration: March 08, 2022

No longer available for credit.

Share

Faculty

Renslow Sherer

Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Merck Sharp & Dohme Corp.

Regeneron Pharmaceuticals, Inc.

Partners

IAS 2018

ProCE Banner

IAS COVID

ProCE Banner

Faculty Disclosure

Primary Author

Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Renslow Sherer, MD, has no relevant conflicts of interest to report.